Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cutaneous Pathology|July 20, 2012
BRAF, NRAS and KIT sequencing analysis of spindle cell melanomaJinhyun Kim, Alexander J Lazar, Michael A Davies, et al.
Future Oncology (London, England)|January 11, 2025
CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinomaSoo J Park, David M Ellison, Ryan Weight, et al.
Annals of Surgical Oncology|July 1, 2021
High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical ReviewFlora Yan, Brittny N Tillman, Rajiv I Nijhawan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignanciesJade Homsi, George R Simon, Chris R Garrett, et al.
American Journal of Clinical Oncology|March 7, 2018
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the LiverJesus Vera-Aguilera, Agop Y Bedikian, Roland L Bassett, et al.
Cancer Immunology Research|March 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor DevelopmentYubo He, Chengcheng Zhang, Lingxiao Tan, et al.
Frontiers in Immunology|May 1, 2024
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practiceMitchell S von Itzstein, Yuqiu Yang, Yiqing Wang, et al.
Cancer Immunology Research|December 19, 2023
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor DevelopmentRyan Huang, Xiaoye Liu, Jaehyup Kim, et al.
Translational Oncology|June 7, 2023
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitorsVatsala Mundra, Yuqiu Yang, Mitchell S von Itzstein, et al.
Pageof 6